title: The value of hysteroscopic-based decision-making in uterine abnormalities during tamoxifen intake in breast cancer patients - preliminary report.
abstract: Women using hormonal therapy for breast cancer are often encountered in clinical practice of breast surgeons, oncologists and gynecologists. Some of them during the course of therapy develop abnormal uterine bleeding or have ultrasound abnormalities detected. In Poland, most of them are still diagnosed using blind curettage, which does not bring a definitive diagnosis or requires repeating the diagnostic procedure. This produces unnecessary fear of malignancy in patients and increases economic costs (double curettage, unnecessary hysterectomy and its social consequences). Therefore, we studied the usefulness of hysteroscopy with targeted biopsies for further management of women treated with tamoxifen. Our goal is to provide evidence that women before entering, during and after tamoxifen treatment have hysteroscopy for endometrial assessment.
authors.affiliation: Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Katowice, Poland.
authors.forename: Iwona
authors.initials: I
authors.lastname: Gabriel
authors.affiliation: Department of Gynecology, Obstetrics and Oncological Gynecology, Medical University of Silesia, Katowice, Poland.
authors.forename: Anita
authors.initials: A
authors.lastname: Olejek
keywords: assessment; breast cancer; endometrium; hysteroscopy; tamoxifen
references.citation: Menopause. 2013 Jan;20(1):64-71
references.pmid: 22968254
references.citation: J Exp Clin Cancer Res. 2002 Mar;21(1):37-43
references.pmid: 12071527
references.citation: J Minim Invasive Gynecol. 2013 Jan-Feb;20(1):56-63
references.pmid: 23107759
references.citation: J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):62-7
references.pmid: 15104834
references.citation: Chin Med J (Engl). 2011 Aug;124(15):2335-9
references.pmid: 21933565
references.citation: Ginekol Pol. 2002 Nov;73(11):1109-12
references.pmid: 12722407